Back to Saturn V Capital Management LP
Saturn V Capital Management LP
Q2 2026 13F filing
Updated 27 days ago23 disclosed positions worth $697.5M
Portfolio value
$697.5M
Total holdings
23
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AMLX AMYLYX PHARMACEUTICALS INC | $83M | 4.62M | 11.91% | — |
| 2 | A ALMS ALUMIS INC | $82M | 2.92M | 11.76% | — |
| 3 | A AAVXF ABIVAX SA | $69.1M | 518.9K | 9.91% | — |
| 4 | P PCVX VAXCYTE INC | $49.6M | 852.9K | 7.11% | — |
| 5 | ? N/A IMMIX BIOPHARMA INC | $48M | 4.66M | 6.89% | — |
| 6 | P PHVS PHARVARIS N V | $45.4M | 1.31M | 6.52% | — |
| 7 | J JAZZ JAZZ PHARMACEUTICALS PLC | $38.8M | 160.9K | 5.56% | — |
| 8 | C CELC CELCUITY INC | $38.7M | 370.3K | 5.55% | — |
| 9 | I IRON DISC MEDICINE INC | $38.4M | 524.7K | 5.50% | — |
| 10 | C CGC CANDEL THERAPEUTICS INC | $34M | 3.30M | 4.88% | — |
| 11 | ? N/A X4 PHARMACEUTICALS INC | $32.6M | 6.97M | 4.67% | — |
| 12 | M MNPR MONOPAR THERAPEUTICS INC | $28.9M | 312.0K | 4.14% | — |
| 13 | D DYN DYNE THERAPEUTICS INC | $23.5M | 1.06M | 3.37% | — |
| 14 | T TRVI TREVI THERAPEUTICS INC | $19.6M | 1.05M | 2.81% | — |
| 15 | Z ZURA ZURA BIO LTD | $12.4M | 2.10M | 1.78% | — |
| 16 | S SGMT SAGIMET BIOSCIENCES INC | $11.4M | 1.48M | 1.64% | — |
| 17 | O OCSAW OCULIS HOLDING AG | $9.5M | 684.9K | 1.36% | — |
| 18 | I IKT INHIBIKASE THERAPEUTICS INC | $7.9M | 3.87M | 1.13% | — |
| 19 | V VIR VIR BIOTECHNOLOGY INC | $7.9M | 770.6K | 1.13% | — |
| 20 | I IVVD INVIVYD INC | $7.3M | 8.39M | 1.05% | — |
| 21 | A ANRO ALTO NEUROSCIENCE INC | $4.8M | 182.8K | 0.69% | — |
| 22 | M MSLE SATELLOS BIOSCIENCE INC | $2.7M | 350.0K | 0.39% | — |
| 23 | O OVID OVID THERAPEUTICS INC | $1.8M | 663.1K | 0.26% | — |